Carolyn J. Edwards
Cambridge, ENG CB223AT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.
Journal: EMBO molecular medicine
Published: January 12, 2024
The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity.
Journal: British journal of cancer
Published: July 15, 2021
Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse.
Journal: New biotechnology
Published: June 25, 2019
Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
Journal: Nature immunology
Published: June 19, 2015
Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
Journal: Nature immunology
Published: April 22, 2015
High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.
Journal: Journal of virology
Published: September 13, 2013
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization.
Journal: The Journal of experimental medicine
Published: May 30, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026